Human PlGF-3

Placenta growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family and promotes endothelial cell growth and angiogenesis.  PlGF is secreted as a homodimer and may also form a heterodimer with VEGF. 

SKU Select size Price Buy
100-198-5ug Mini: 5 ug $63.00 + -
100-198-25ug Std.: 25 ug $158.00 + -
100-198-100ug Value: 100 ug $510.00 + -
100-198-500ug Midgi: 500 ug $1,701.00 + -
100-198-1mg Mg: 1 mg $2,835.00 + -
100-198AF-5ug Animal-Free Mini: 5 ug $69.00 + -
100-198AF-25ug Animal-Free Std.: 25 ug $174.00 + -
100-198AF-100ug Animal-Free Value: 100 ug $562.00 + -
100-198AF-500ug Animal-Free Midgi: 500 ug $1,869.00 + -
100-198AF-1mg Animal-Free Mg: 1 mg $3,119.00 + -
Alternate Names:  None                     Accession Number: P49763   
Description:  Placenta growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family and promotes endothelial cell growth and angiogenesis.  PlGF is secreted as a homodimer and may also form a heterodimer with VEGF.  PlGF is detected in the placenta, heart, lungs, thyroid, and adipose tissues.  Circulating PlGF levels are correlated with colorectal and renal cancers, as well as atherosclerosis and ischemic heart disease.  There are four alternatively spliced PlGF isoforms (PlGF-1, PlGF-2, PlGF-3, and PlGF-4), each with unique secretion patterns and heparin-binding affinities.  PlGF-3 lacks a heparin-binding domain and signals through the VEGFR-1 receptor. 
Source:  Genetically modified E.coli
Predicted MW:  Dimer, 22.9/45.8 kDa (with 204/408 amino acids)
AA Sequence:  MLPAVPPQQW ALSAGNGSSE VEVVPFQEVW GRSYCRALER LVDVVSEYPS EVEHMFSPSC VSLLRCTGCC GDENLHCVPV ETANVTMQLL KIRSGDRPSY VELTFSQHVR CECRHSPGRQ SPDMPGDFRA DAPSFLPPRR SLPMLFRMEW GCALTGSQSA VWPSSPVPEE IPRMHPGRNG KKQQRKPLRE KMKPERCGDA VPRR
Formulation:  Lyophilized from a sterile (0.2 micron) filtered aqueous solution containing 0.1% Trifluoroacetic Acid (TFA)

Product Specifications*
*Lot-specific values for the following specifications are supplied with each production lot on its corresponding COA. The values provided here are minimum expected values to pass internal requirements. 

Specification

Method of Determination

Acceptance Criteria

Purity

Reducing and Non-Reducing SDS-PAGE

≥ 95%

Endotoxin

Kinetic LAL (50% confidence)

≤ 1 EUs/µg

Biological Activity

No biological activity data is available at this time

 No biological activity data is available at this time


Preparation and Storage

Country of Origin:  USA        Shipping:  Room temperature             
Storage Prior to Reconstitution:  -20°C
Product Reconstitution:  Sterile water at 0.1 mg/mL 

Instructions:  Centrifuge vial before opening.  Suspend the product by gently pipetting the above recommended solution down the sides of the vial.  DO NOT VORTEX.  Allow several minutes for complete reconstitution.  For prolonged storage, dilute to working aliquots in a 0.1% BSA solution, store at -80°C and avoid repeat freeze thaws.   

Expiration Date:                      
12 months from date of receipt when stored at -20°C to -80°C as supplied. 
1 month when stored at 4°C after reconstituting as directed.
3 months when stored at -20°C to -80°C after reconstituting as directed.

To receive more information or a bulk quote, email us at quotes@shenandoah-bt.com.

 

Product Datasheets Certificates of Analysis Certificates of Origin
PDS Lot 0516 Lot 0516
SDS Lot 0516 Animal-Free Lot 0616
PDS Animal-Free    
SDS Animal-Free    

 

 

Related products